Recent Finacing
Recent Raise
Bioheng Biotech develops allogeneic cellular immunotherapies for immediate cancer treatment, operating a 75,000 sq ft GMP translational and semi-automated manufacturing facility compliant with NMPA and FDA guidelines.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
